We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Venture Life Group Plc | LSE:VLG | London | Ordinary Share | GB00BFPM8908 | ORD 0.3P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.00 | -2.55% | 38.25 | 37.50 | 39.00 | 39.25 | 38.25 | 39.25 | 188,697 | 09:18:05 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Misc Retail Stores, Nec | 43.98M | 520k | 0.0041 | 93.29 | 48.13M |
TIDMVLG
Venture Life Group PLC
05 March 2018
5 March 2018
Venture Life Group plc
("Venture Life" or the "Group")
Notice of Results
Analyst & investor briefings
Venture Life Group plc (AIM: VLG), the international consumer healthcare group focused on developing, manufacturing and commercialising products for the self-care market, announces that it will release its final results for the year ended 31 December 2017 on 22 March 2018.
Analyst briefing
A briefing for analysts will take place at the offices of Walbrook PR, 4 Lombard St., London EC3V 9HD at 9.30am on Thursday, 22 March 2018.
Investor briefing
A presentation to private investors will take place at Copper Bar, Balls Brothers, 6 Adams Court, Old Broad Street, London EC2N 1DX on Monday, 26 March 2018 from 4.30pm for a 4.45pm start and will be followed by drinks.
If you would like to register to attend either briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email venturelife@walbrookpr.com.
For further information, please contact:
Hot Features
Premium
Venture Life Group PLC +44 (0) 1344 742870
Jerry Randall, Chief Executive
Officer
Adrian Crockett, Chief Financial
Officer
Walbrook PR venturelife@walbrookpr.com
or +44 (0) 20 7933 8780
+44 (0) 7980 541
Paul McManus 893
+44 (0) 7876 741
Anna Dunphy 001
About Venture Life (www.venture-life.com)
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising self-care products globally. The Group's product range and pipeline currently includes the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, dermo-cosmetics for addressing the signs of ageing, and medical devices for improving minor aches and pains, dry eyes and itchy skin.
The products, which typically are recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners.
Through its Development & Manufacturing business, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRALLFERVTIFIIT
(END) Dow Jones Newswires
March 05, 2018 02:00 ET (07:00 GMT)
1 Year Venture Life Chart |
1 Month Venture Life Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
